Hzymes to Present Ultra-Low Bioburden Enzymatic Solutions for Next-Generation Sequencing at I-MDx 2025
Source: Hzymes Market Center
Date: 2025-04-23
Views: 135
Nanjing, China — Hzymes, a leading innovator in high-purity molecular enzyme development, is excited to announce its participation in I-MDx 2025 – The 7th Molecular Diagnostics Industry Conference and Exhibition, taking place on April 24–25, 2025. The company will present its ultra-clean enzymatic solutions tailored for next-generation sequencing (NGS) and molecular diagnostics (MDx) at Booth A20, offering attendees a firsthand look at its advanced technologies designed to enhance precision medicine.



Driving Innovation in Molecular Diagnostics


With the rapid advancement of metagenomic next-generation sequencing (mNGS) and PCR-based diagnostics, the demand for high-purity, low-bioburden enzymatic reagents has never been greater. Hzymes’ ultra-clean enzyme development platform ensures superior performance in sensitive applications, making it an ideal partner for clinical diagnostics, infectious disease detection, and cancer genomics.



Key Highlights of Hzymes’ Offerings:


1.Ultra-Low Bioburden Reagents for mNGS


Protease K (mNGS Grade) 


– Optimized for nucleic acid extraction with minimal contamination risk.


High-Purity dNTP Mixes (10mM & 25mM, mNGS Grade) 


– Essential for error-free amplification in NGS workflows.


2.High-Capacity Manufacturing & Quality Assurance


ISO 9001 & ISO 13485 certified production facilities.


Multi-scale chromatography systems for flexible, scalable manufacturing.


3.Proven Expertise in Molecular Biology


Successfully delivered 1,000+ projects for global partners.


Specialized in complex purification processes to ensure enzyme stability and activity.



Why Visit Hzymes at Booth A20?


Attendees at I-MDx 2025 will have the opportunity to:


✔ Explore novel enzymatic formulations for NGS, qPCR, and CRISPR-based diagnostics.
✔ Discuss custom development services for tailored assay optimization.
✔ Learn how Hzymes’ quality control systems minimize batch-to-batch variability.



A Trusted Partner in Precision Medicine


As molecular diagnostics continues to evolve, Hzymes remains committed to delivering reliable, contamination-free reagents that meet the stringent demands of clinical and research laboratories. By leveraging its proprietary purification technologies and strict environmental controls, the company ensures that its products meet the highest industry standards.


Join Hzymes at Booth A20 to discover how our innovations can elevate your molecular diagnostics workflows.
Message
Leave Your Message
Name *
Company *
Tel/WhatsApp *
Mail *
Nation *
Descriptions

Please contact on WhatsApp

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

  • iso_copy_copy
  • iso_copy
  • iso
  • iso_copy_copy
  • iso_copy
  • iso
Contact Us

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |